HEPATITIS C VIRUS INHIBITORS
The present disclosure relates to the preparation of a compound for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pyrrolidinyl or biphenyl derivatives which are used in a process for preparing the HCV inhibiting compound.
Saved in:
| Main Authors | , , , , , , , , , , , , , , , , , , |
|---|---|
| Format | Patent |
| Language | English Slovenian |
| Published |
29.06.2018
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The present disclosure relates to the preparation of a compound for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pyrrolidinyl or biphenyl derivatives which are used in a process for preparing the HCV inhibiting compound. |
|---|---|
| AbstractList | The present disclosure relates to the preparation of a compound for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pyrrolidinyl or biphenyl derivatives which are used in a process for preparing the HCV inhibiting compound. |
| Author | NGUYEN Van N SNYDER Lawrence B BACHAND Carol JAMES Clint A RUEDIGER Edward H GOODRICH Jason LAVOIE Rico DEON Daniel H YANG Fukang HAMANN Lawrence G LOPEZ Omar D GOOD Andrew C MEANWELL Nicholas A BELEMA Makonen ST. LAURENT Denis R WANG Gan LANGLEY David R ROMINE Jeffrey Lee MARTEL Alain |
| Author_xml | – fullname: GOODRICH Jason – fullname: LANGLEY David R – fullname: MARTEL Alain – fullname: HAMANN Lawrence G – fullname: JAMES Clint A – fullname: RUEDIGER Edward H – fullname: WANG Gan – fullname: YANG Fukang – fullname: MEANWELL Nicholas A – fullname: ST. LAURENT Denis R – fullname: GOOD Andrew C – fullname: ROMINE Jeffrey Lee – fullname: SNYDER Lawrence B – fullname: BACHAND Carol – fullname: NGUYEN Van N – fullname: LAVOIE Rico – fullname: DEON Daniel H – fullname: BELEMA Makonen – fullname: LOPEZ Omar D |
| BookMark | eNrjYmDJy89L5WSQ8XANcAzxDPEMVnBWCPMMCg1W8PTz8HTyDPEPCuZhYE1LzClO5YXS3AyKbq4hzh66qQX58anFBYnJqXmpJfHBnsYGJkaWBoYhIYbGxKgBAFklIw8 |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| DocumentTitleAlternate | INHIBITORJI VIRUSA HEPATITISA C |
| ExternalDocumentID | SI3042901TT1 |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_SI3042901TT13 |
| IEDL.DBID | EVB |
| IngestDate | Fri Jul 19 13:01:17 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English Slovenian |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_SI3042901TT13 |
| Notes | Application Number: SI20070032006T |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180629&DB=EPODOC&CC=SI&NR=3042901T1 |
| ParticipantIDs | epo_espacenet_SI3042901TT1 |
| PublicationCentury | 2000 |
| PublicationDate | 20180629 |
| PublicationDateYYYYMMDD | 2018-06-29 |
| PublicationDate_xml | – month: 06 year: 2018 text: 20180629 day: 29 |
| PublicationDecade | 2010 |
| PublicationYear | 2018 |
| RelatedCompanies | Bristol-Myers Squib Holdings Ireland |
| RelatedCompanies_xml | – name: Bristol-Myers Squib Holdings Ireland |
| Score | 3.147841 |
| Snippet | The present disclosure relates to the preparation of a compound for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pyrrolidinyl or... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| Title | HEPATITIS C VIRUS INHIBITORS |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180629&DB=EPODOC&locale=&CC=SI&NR=3042901T1 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3PS8MwFH6MKepNp6JzSgXZrbiuTZseirh0oxG2lTYbu42mS2EwdNiK_76vYVMvegsJvCQPXr58yfsB8ICIWOSF45qK9JXpeKowpU-IqfwiI1LmHtXZ-ccTN5o5LwuyaMB6Hwuj84R-6uSIaFE52nulz-vtzyNWqH0ry0e5xq63p5EIwu6OHVu05yKBDgfBMJ6GU9ZlLEh5d5IENWtH6BNIlA7wFu1pzjYf1EEp29-IMjqFwxiFvVZn0Cg3LThm-8JrLTga7_67sbkzvfIcOtEwfhZc8NRgxpwns9Tgk4gPuJgm6QXcj4aCRSZOs_ze0jLl-wUJy76EJlJ9dQWGtGVOkbGtrII4FvWon2erTNVqs7OeotfQ_ltO-7_BGzip1VM7OfX9DjSr9w91i3BayTutiC8siXdR |
| link.rule.ids | 230,309,783,888,25577,76883 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3NS8MwFH-MKc6bTkXn1ArSW3Fd2y09FLHtRqPrB202dhtNl8JAdLiK_76vYVMvegsJvCQPXn75Je8D4A4RsSxKc6AJqy80cyhKjduWpQm7zC3OiyGR2fnDaBBMzae5NW_AahcLI_OEfsrkiGhRBdp7Jc_r9c8jli99Kzf3fIVdbw9j5vjqlh3rpDdAAu27ziiJ_dhTPc_JqBqlTs3aEfoYEqU9vGETyZRmbh2Usv6NKOMj2E9Q2Gt1DI3NSxta3q7wWhsOwu1_Nza3prc5gW4wSh4ZZTRTPGVG02mm0CigLmVxmp3C7XjEvEDDaRbfW1pkdLcgphtn0ESqL85B4QYvCDK2pV5apk6GxC7yZS5qtRl5T5AL6Pwtp_Pf4A20AhZOFhMaPV_CYa2q2uGpb3ehWb1_iCuE1opfS6V8AeucekE |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=HEPATITIS+C+VIRUS+INHIBITORS&rft.inventor=GOODRICH+Jason&rft.inventor=LANGLEY+David+R&rft.inventor=MARTEL+Alain&rft.inventor=HAMANN+Lawrence+G&rft.inventor=JAMES+Clint+A&rft.inventor=RUEDIGER+Edward+H&rft.inventor=WANG+Gan&rft.inventor=YANG+Fukang&rft.inventor=MEANWELL+Nicholas+A&rft.inventor=ST.+LAURENT+Denis+R&rft.inventor=GOOD+Andrew+C&rft.inventor=ROMINE+Jeffrey+Lee&rft.inventor=SNYDER+Lawrence+B&rft.inventor=BACHAND+Carol&rft.inventor=NGUYEN+Van+N&rft.inventor=LAVOIE+Rico&rft.inventor=DEON+Daniel+H&rft.inventor=BELEMA+Makonen&rft.inventor=LOPEZ+Omar+D&rft.date=2018-06-29&rft.externalDBID=T1&rft.externalDocID=SI3042901TT1 |